D.Y.C. Heng

Risk and predictors of suicide in colorectal cancer patients: a Surveillance, Epidemiology, and End Results analysis.

W. Cheung, H. Samawi, P. Tang, 2017, Current oncology.

Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer.

Aalok Kumar, J. Monzon, C. Doll, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.

T. Choueiri, N. Agarwal, M. Harrison, 2019, The Lancet. Oncology.

Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

T. Choueiri, N. Agarwal, I. Davis, 2019, Current oncology.

Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors

R. Sangha, I. Stukalin, A. Pabani, 2024, JAMA network open.

Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review.

G. De Velasco, B. McGregor, N. Tannir, 2023, Cancer treatment reviews.

Imaging response to immune checkpoint inhibitors in patients with advanced melanoma: a retrospective observational cohort study

I. Stukalin, D. Meyers, V. Navani, 2024, Frontiers in oncology.

Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma

M. Sander, I. Stukalin, B. Ewanchuk, 2023, Current oncology.